类风湿关节炎关节炎前阶段的干预窗口?关键触发事件与潜在预防策略的叙述性综述
本文综述类风湿关节炎(RA)发病前(风险阶段)的触发机制与预防策略。已获批的RA治疗在风险阶段用于预防未显示足以支持诊断前使用的效果。RA起病前异质性类似诊断后,干预时机与受试者选择对未来潜在干预的成功至关重要。
要点
- 已获批RA治疗在风险阶段预防RA未显示足以支持诊断前使用的效果。
- RA起病前异质性与诊断后相似,干预时机和受试者选择至关重要。
- 黏膜表面在打破自身耐受和触发关节炎中的作用是研究重点。
核心结论
- 已获批的RA治疗在风险阶段用于预防未显示足以支持诊断前使用的效果。
- 对RA发病前阶段的理解仍不完整,RA起病前异质性与诊断后相似。
- 干预时机和受试者选择将是未来潜在干预成功的关键。
研究设计与样本
- 叙述性综述,聚焦RA关节炎起病前的发育机制与预防策略。
主要发现
- 已获批RA治疗在风险阶段预防RA未显示足以支持诊断前使用的效果。
- 研究聚焦适应性免疫系统偏差及黏膜表面在打破自身耐受和触发关节炎中的作用。
- RA起病前异质性与诊断后所见相似。
关键数值与推荐
- 已获批RA治疗在风险阶段预防RA未显示足以支持诊断前使用的效果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 对RA发病前阶段的理解仍不完整。
- 现有研究强调RA起病前异质性与诊断后相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) is an autoimmune disease that often evolves over several years, which in the presence of risk factors, is termed the at-risk phase. Several of the currently approved treatments for RA have been evaluated for the prevention of RA during the at-risk phase, but without showing effects sufficient to warrant their use prior to diagnosis. There is an ongoing surge in research efforts to understand mechanisms underlying the onset of RA, in particular concerning deviations in the adaptive immune system and the role of mucosal surfaces in the breach of self-tolerance and triggering of arthritis. With this focus, we here aimed to review current knowledge on RA development prior to arthritis onset. Also, since the pre-arthritis phase may contain windows of opportunity to prevent RA onset, we present and conceptualise different strategies to potentially interfere with steps leading to RA. While the body of knowledge is increasing, our understanding of RA development remains incomplete, and available studies highlight that RA appears similarly heterogeneous prior to onset as is seen after diagnosis. Hence, the timing and the selection of subjects will be crucial for the success of future potential interventions.
引用
- Kastbom A, Turcinov S, Malmström V, et al. Windows for intervention in the prearthritis phase of rheumatoid arthritis? A narrative review of key triggering events and potential preventive strategies. RMD Open. 2025. PMID: 40639878. doi:10.1136/rmdopen-2025-005778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。